ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX

Provided By PR Newswire

Last update: Feb 3, 2024

NEW YORK, Feb. 3, 2024 /PRNewswire/ --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) between August 8, 2023 and November 28, 2023, both dates inclusive (the "Class Period"), of the important February 9, 2024 lead plaintiff deadline.